NRG-GY033: Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors (clinicaltrials.gov) - Jul 29, 2026 - P2 | N=17 | Active, not recruiting | Sponsor: National Cancer Institute (NCI) | N=37 ➔ 17 | Trial primary completion date: May 2027 ➔ Feb 2026
Enrollment change • Trial primary completion date • Oncology • Ovarian Cancer
|